Business Standard

SMS Pharmaceuticals' Bachupally facility Unit II successfully completes USFDA inspection

Image

Capital Market

Receives Zero Form 483 observations

SMS Pharmaceuticals has successfully completed, its Fifth US Food and Drug Administration (USFDA) inspection for its Manufacturing facility - Unit-II, located at Plot No.24 & 24B and 36 & 37, S.V. Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad-500 090, Telangana, India.

No Form 483 observations were issued during the inspection.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 20 2017 | 11:31 AM IST

Explore News